These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 32551844

  • 1. Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.
    Urban MJ, Moore DM, Kwarta K, Leonetti J, Rajasekhar R, Gluth MB, Wiet RM.
    Ann Otol Rhinol Laryngol; 2020 Dec; 129(12):1229-1238. PubMed ID: 32551844
    [Abstract] [Full Text] [Related]

  • 2. Cochlear implantation after radiosurgery for vestibular schwannoma.
    Patel NS, Carlson ML, Link MJ, Neff BA, Van Gompel JJ, Driscoll CLW.
    J Neurosurg; 2021 Jul 01; 135(1):126-135. PubMed ID: 34250789
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Cochlear Implantation in Neurofibromatosis Type 2 Related Hearing Loss.
    Sobczak G, Marchant W, Misurelli S, Pyle GM, Gubbels S, Roche J.
    Ann Otol Rhinol Laryngol; 2023 Mar 01; 132(3):284-293. PubMed ID: 35450430
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.
    Neff BA, Wiet RM, Lasak JM, Cohen NL, Pillsbury HC, Ramsden RT, Welling DB.
    Laryngoscope; 2007 Jun 01; 117(6):1069-72. PubMed ID: 17545869
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. NF2-Related Intravestibular Schwannomas: Long-Term Outcomes of Cochlear Implantation.
    Jia H, Nguyen Y, Hochet B, Smail M, Mosnier I, Wu H, Sterkers O, Kalamarides M, Bernardeschi D.
    Otol Neurotol; 2020 Jan 01; 41(1):94-99. PubMed ID: 31634276
    [Abstract] [Full Text] [Related]

  • 8. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
    Harris F, Tysome JR, Donnelly N, Durie-Gair J, Crundwell G, Tam YC, Knight RD, Vanat ZH, Folland N, Axon P.
    Cochlear Implants Int; 2017 May 01; 18(3):171-179. PubMed ID: 28335700
    [Abstract] [Full Text] [Related]

  • 9. Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2.
    Tan H, Jia H, Li Y, Zhang Z, Zhu W, Cai Y, Wang Z, Wu H.
    Eur Arch Otorhinolaryngol; 2018 Nov 01; 275(11):2667-2674. PubMed ID: 30229456
    [Abstract] [Full Text] [Related]

  • 10. Cochlear Implantation After Radiotherapy of Vestibular Schwannomas.
    Tian L, West N, Cayé-Thomasen P.
    J Int Adv Otol; 2021 Sep 01; 17(5):452-460. PubMed ID: 34617898
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparing Speech Recognition Outcomes Between Cochlear Implants and Auditory Brainstem Implants in Patients With NF2-Related Schwannomatosis.
    Dornhoffer JR, Plitt AR, Lohse CM, Driscoll CLW, Neff BA, Saoji AA, Van Gompel JJ, Link MJ, Carlson ML.
    Otol Neurotol; 2024 Jan 01; 45(1):29-35. PubMed ID: 37875011
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
    Carlson ML, Breen JT, Driscoll CL, Link MJ, Neff BA, Gifford RH, Beatty CW.
    Otol Neurotol; 2012 Jul 01; 33(5):853-62. PubMed ID: 22664900
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
    North HJ, Mawman D, O'Driscoll M, Freeman SR, Rutherford SA, King AT, Hammerbeck-Ward C, Evans DG, Lloyd SK.
    Cochlear Implants Int; 2016 Jul 01; 17(4):172-177. PubMed ID: 27691934
    [Abstract] [Full Text] [Related]

  • 20. Auditory brainstem implants in NF2 patients: results and review of the literature.
    Sanna M, Di Lella F, Guida M, Merkus P.
    Otol Neurotol; 2012 Feb 01; 33(2):154-64. PubMed ID: 22246383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.